Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

      November 7, 2025
      Research & Development

      Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

      August 31, 2025
      Research & Development

      Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

      July 30, 2025
      Research & Development

      $20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

      July 11, 2025
  • Clinical
    • Clinical

      Evommune Reports Phase 2a EVO301 Data in Moderate to Severe Atopic Dermatitis

      February 12, 2026
      Clinical

      Eli Lilly Discontinues Three Clinical-Stage Programs Including Prevail Gene Therapy

      February 12, 2026
      Clinical

      CagriSema Shows Greater Blood Sugar and Weight Reduction Than Semaglutide in Phase 3 Trial

      February 4, 2026
      Clinical

      Sanofi Reports Divergent Phase III Results for Venglustat in Gaucher and Fabry Diseases

      February 4, 2026
  • Commercial
    • AllBrand & Marketing
      Commercial

      Lilly Acquires Orna to Enter In Vivo CAR-T Development for Autoimmune Diseases

      February 12, 2026
      Commercial

      Iambic and Takeda Enter Multiyear AI Drug Discovery Partnership Valued at Over $1.7 Billion

      February 12, 2026
      Commercial

      AstraZeneca commits $15 billion investment in China to advance radioconjugates and cell therapy innovation

      February 4, 2026
  • Technology
    • Technology

      Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

      July 7, 2025
      Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
      Technology

      PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

      September 26, 2024
  • Insights
    • Insights

      Reg impact assessment next in GenAI’s sights, experts claim

      June 26, 2025
      Insights

      The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

      December 1, 2024
      Insights

      Improving life science R&D outcomes with AI

      November 8, 2024
      Insights

      The medical device sector’s surging regulatory burden: how are suppliers coping?

      October 12, 2024
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
Twitter
Home Tags Mallinckrodt

Tag: Mallinckrodt

Mallinckrodt gets ready for company restructuring | After opioid-meltdown,
Commercial

After opioid-meltdown, Mallinckrodt gets ready for company restructuring

Editorial Team -
September 16, 2021
0

Editor Picks

Iveric Receives FDA Approval for Geographic Atrophy Following Astellas’ Purchase

August 8, 2023

VectorY Secures Option to Evaluate Shape Therapeutics’ Brain-Penetrating Gene Therapy Technology

September 24, 2025

AstraZeneca and RQ Biotech enter into licensing agreement to develop antibodies against COVID-19

May 21, 2022

Must Read

Evommune Reports Phase 2a EVO301 Data in Moderate to Severe Atopic Dermatitis

February 12, 2026

FDA Rejects REGENXBIO’s RGX-121 Gene Therapy for Hunter Syndrome, Requests New Study

February 12, 2026

Eli Lilly Discontinues Three Clinical-Stage Programs Including Prevail Gene Therapy

February 12, 2026

Hot Topics

  • Clinical391
  • Commercial366
  • Regulatory306
  • Research & Development102
  • Manufacturing79
  • Newsletter59
  • Technology40
  • News31
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
Twitter

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial